Skip to main content

ADVERTISEMENT

Videos

AJ Gunn, MD, University of Alabama at Birmingham
Videos
04/11/2024

Featuring AJ Gunn, MD

Featuring AJ Gunn, MD
At the 2024 SIR Annual Meeting, AJ Gunn, MD, University of Alabama at Birmingham, discussed treatment for patients with central renal tumors.
At the 2024 SIR Annual Meeting, AJ Gunn, MD, University of Alabama at Birmingham, discussed treatment for patients with central renal tumors.
At the 2024 SIR Annual Meeting,...
04/11/2024
IO Learning
John Allan, MD, Weill Cornell Medicine
Conference Coverage
04/10/2024

Featuring John Allan, MD

Featuring John Allan, MD
John Allan, MD, compares the use of different BTK inhibitors for the treatment of CLL in a frontline setting and discusses whether there is an optimal drug regimen to use among patients with CLL.
John Allan, MD, compares the use of different BTK inhibitors for the treatment of CLL in a frontline setting and discusses whether there is an optimal drug regimen to use among patients with CLL.
John Allan, MD, compares the use...
04/10/2024
Lymphoma, Leukemia & Myeloma Network
Ashley Rosko, MD
Conference Coverage
04/10/2024

Featuring Ashley Rosko, MD

Featuring Ashley Rosko, MD
Ashley Rosko, MD, discusses factors to consider when administering bispecific antibody therapy to patients with multiple myeloma in an outpatient setting, which she discussed at the 2024 Great Debates & Updates in Hematologic Malignancies...
Ashley Rosko, MD, discusses factors to consider when administering bispecific antibody therapy to patients with multiple myeloma in an outpatient setting, which she discussed at the 2024 Great Debates & Updates in Hematologic Malignancies...
Ashley Rosko, MD, discusses...
04/10/2024
Lymphoma, Leukemia & Myeloma Network
Gathering of Eagles Meeting March 8, 2024:
Videos
04/10/2024

Metropolitan EMS Medical Directors Consortium

Metropolitan EMS Medical Directors Co...
Eric Jaeger on the legal fallout of the paramedic convictions in Colorado; Eagles on protocols related to sedation and the agitated patient; Donald Jenkins on FDA requirements related to blood type during emergency administration; Rob Dunne...
Eric Jaeger on the legal fallout of the paramedic convictions in Colorado; Eagles on protocols related to sedation and the agitated patient; Donald Jenkins on FDA requirements related to blood type during emergency administration; Rob Dunne...
Eric Jaeger on the legal fallout...
04/10/2024
EMSWorld
Aditi Shastri, MD, Montefiore Einstein Comprehensive Cancer Center
Conference Coverage
04/10/2024

Featuring Aditi Shastri, MD

Featuring Aditi Shastri, MD
During the 2024 Great Debates & Updates in Hematological Malignancies Meeting, Aditi Shastri, MD, shares expert insight on recent updates in risk stratification and treatment regimens for patients with low to intermediate risk myelodysplastic...
During the 2024 Great Debates & Updates in Hematological Malignancies Meeting, Aditi Shastri, MD, shares expert insight on recent updates in risk stratification and treatment regimens for patients with low to intermediate risk myelodysplastic...
During the 2024 Great Debates &...
04/10/2024
Oncology
Gathering of Eagles Meeting March 1, 2024:
Videos
04/10/2024

Metropolitan EMS Medical Directors' Consortium

Metropolitan EMS Medical Directors' C...
Patients’ and providers’ religious views related to the administration of whole blood; Abdo Khoury on emergency medicine physician shortages in France; Corey Slovis on ECGs and resolved STEMIs; Amal Mattu on “shark fin STEMI”; and more.
Patients’ and providers’ religious views related to the administration of whole blood; Abdo Khoury on emergency medicine physician shortages in France; Corey Slovis on ECGs and resolved STEMIs; Amal Mattu on “shark fin STEMI”; and more.
Patients’ and providers’...
04/10/2024
EMSWorld
Joseph Mikhael, MD, MEd, FRCPC, FACP
Conference Coverage
04/10/2024

Featuring Joseph Mikhael, MD, MEd, FRCPC, FACP

Featuring Joseph Mikhael, MD, MEd, FR...
At the 2024 Great Debates & Updates in Hematologic Malignancies meeting, Joseph Mikhael, MD, MEd, FRCPC, FACP, evaluates whether or not quadruplet therapy should be the new standard-of-care treatment for patients with multiple myeloma who are...
At the 2024 Great Debates & Updates in Hematologic Malignancies meeting, Joseph Mikhael, MD, MEd, FRCPC, FACP, evaluates whether or not quadruplet therapy should be the new standard-of-care treatment for patients with multiple myeloma who are...
At the 2024 Great Debates &...
04/10/2024
Lymphoma, Leukemia & Myeloma Network
Joseph Mikhael, MD, City of Hope Cancer Center
Conference Coverage
04/09/2024

Featuring Joseph Mikhael, MD, MEd, FRCPC, FACP

Featuring Joseph Mikhael, MD, MEd, FR...
During the 2024 Great Debates & Updates in Hematological Malignancies Meeting, Joseph Mikhael, MD, MEd, FRCPC, FACP, shares expert insight on when to choose CAR-T therapy versus bispecific antibodies in multiple myeloma treatment.
During the 2024 Great Debates & Updates in Hematological Malignancies Meeting, Joseph Mikhael, MD, MEd, FRCPC, FACP, shares expert insight on when to choose CAR-T therapy versus bispecific antibodies in multiple myeloma treatment.
During the 2024 Great Debates &...
04/09/2024
Lymphoma, Leukemia & Myeloma Network
Drs Carbray and Phelps
Videos
04/09/2024

Featuring Julie Carbray, PhD, and Jim Phelps, MD 

Featuring Julie Carbray, PhD, and Jim...
Join Drs Phelps Carbray in an insightful discussion on the complexities of diagnosing and treating mood disorders and delve into their strategies for unraveling these diagnostic dilemmas and crafting informed treatment plans.
Join Drs Phelps Carbray in an insightful discussion on the complexities of diagnosing and treating mood disorders and delve into their strategies for unraveling these diagnostic dilemmas and crafting informed treatment plans.
Join Drs Phelps Carbray in an...
04/09/2024
Psych Congress Network